永安药业部分董高层拟合计减持不超23.54万股

Core Viewpoint - Yong'an Pharmaceutical (002365.SZ) announced that several directors and senior management personnel plan to reduce their shareholdings in the company through centralized bidding transactions within three months after a 15 trading day period following the announcement [1] Summary by Relevant Sections - Shareholding Details - A total of 942,000 shares are held by the directors and senior management, accounting for 0.3197% of the total share capital and 0.3258% when excluding shares in the repurchase special account [1] - Planned Reduction - The planned reduction involves a maximum of 235,400 shares, which represents 0.0799% of the total share capital and 0.0814% when excluding shares in the repurchase special account [1] - Control Implications - The share reduction will not lead to any change in the control of the company [1]